文献速递甲状腺疾病

年轻成人与儿童分化型甲状腺癌:临床特征及10年随访结局比较

Differentiated Thyroid Cancers in Young Adults Versus Children: Clinical Characteristics and 10-year Follow-up Outcomes.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

研究比较1971至2016年儿童(≤18岁)与年轻成人(19-39岁)分化型甲状腺癌患者的临床特征与治疗结局。共纳入1803例,儿童176例、年轻成人1627例。儿童基线不良特征更常见,年轻成人2年不完全反应率更低、复发/持续病灶更少、10年无病生存率更高。

要点

  • 儿童分化型甲状腺癌较年轻成人更常见甲状腺外侵犯、淋巴结及远处转移和ATA高危。
  • 年轻成人2年不完全反应率13.7%,低于儿童的53.4%(P<.001)。
  • 年轻成人10年无病生存率93.6%,高于儿童的88.7%(P=.007)。

核心结论

  • 年轻成人分化型甲状腺癌较儿童侵袭性更低,长期结局良好。

研究设计与样本

  • 研究纳入1971至2016年儿童(≤18岁)和年轻成人(19-39岁)分化型甲状腺癌患者,共1803例,其中儿童176例、年轻成人1627例。

主要发现

  • 儿童组甲状腺外侵犯(P=.040)、淋巴结转移、远处转移及美国甲状腺协会高危疾病(各P<.001)均更常见。
  • 治疗后2年,年轻成人组不完全反应为223/1627(13.7%),低于儿童组的94/176(53.4%),P<.001。
  • 中位随访10.7年,年轻成人组复发/持续病灶为120/1627(7.4%),低于儿童组的23/176(13.1%),P=.012。
  • 10年无病生存概率年轻成人组为93.6%,高于儿童组的88.7%,P=.007。
  • 在年轻成人队列中,美国甲状腺协会高危疾病和2年不完全反应均为无病生存显著更差的独立预测因素(各P<.001)。

关键数值与推荐

  • 儿童组甲状腺外侵犯P=.040;淋巴结转移、远处转移及美国甲状腺协会高危疾病各P<.001。
  • 2年不完全反应:年轻成人组223/1627(13.7%)vs 儿童组94/176(53.4%),P<.001。
  • 复发/持续病灶:年轻成人组120/1627(7.4%)vs 儿童组23/176(13.1%),P=.012。
  • 10年无病生存概率:年轻成人组93.6% vs 儿童组88.7%,P=.007。

临床怎么用

  • 作者认为,适当的初始和动态风险分层有助于优化治疗决策和随访策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Differentiated thyroid cancer (DTC) in young adults has been steadily rising in incidence over the decades. However, data on long-term outcomes in this specific cohort remain limited. In this study, we intended to evaluate young adults with DTC with regard to their clinical characteristics and treatment outcomes and compare the same vis-à-vis pediatric patients with DTC. METHODS: Data of pediatric (≤18 years) and young adult (19-39 years) patients with DTC, from 1971 to 2016, were sequentially extracted and analyzed for clinical characteristics, treatment responses, rates of recurrent/persistent disease, and disease-free survival (DFS). RESULTS: A total of 1803 patients with DTC were included (pediatric cohort: n = 176; young adult cohort: n = 1627). Pediatric patients with DTC had more frequent adverse baseline features including extrathyroidal extension (P = .040), nodal and distant metastases, and American Thyroid Association high-risk disease (P < .001 each). At 2 years posttreatment, young adult patients with DTC had significantly lower incomplete responses compared with pediatric patients with DTC (223/1627; 13.7% vs 94/176, 53.4%, respectively; P < .001). Over a median follow-up of 10.7 years, 120/1627 (7.4%) young adult patients with DTC had recurrent/persistent disease vs 23/176 (13.1%) pediatric patients with DTC (P = .012). The 10-year DFS probability was 93.6% for the young adult patients with DTC vs 88.7% for the pediatric patients with DTC (P = .007). American Thyroid Association high-risk disease and incomplete response at 2 years were independent predictors of significantly worse DFS in the young adult cohort (P < .001 each). CONCLUSIONS: Young adult DTCs behave less aggressively compared with their pediatric counterparts with excellent long-term outcomes. Appropriate initial and dynamic risk stratification can help optimize treatment decisions and follow-up strategies.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Satapathy S, Majeed AK, Ballal S, et al. Differentiated Thyroid Cancers in Young Adults Versus Children: Clinical Characteristics and 10-year Follow-up Outcomes. J Clin Endocrinol Metab. 2023. PMID: 37285485. doi:10.1210/clinem/dgad343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。